Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures sink as Amazon, Intel intensify AI spending fears
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| ENDOCYTE (NASDAQ: ECYT) | Delayed: 23.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.99 | 52 Week High | $4.89 | |||
| Open | $25.06 | 52 Week Low | $2.62 | |||
| Day High | $23.99 | P/E | N/A | |||
| Day Low | $23.99 | EPS | $-0.44 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 146.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.33 | 52 Week High | $65.46 | |||
| Open | $146.33 | 52 Week Low | $47.97 | |||
| Day High | $146.33 | P/E | 99.54 | |||
| Day Low | $146.33 | EPS | $1.47 | |||
| Volume | 22,012 | |||||
